GSK

(LSE) GSK

Current Price£19.20

Market Cap£76.28B

Since IPO (1992)+834%

5 Year+40%

1 Year+27%

1 Month+2%

GSK Financials at a Glance

Market Cap

£76.28B

Revenue (TTM)

£32.78B

Net Income (TTM)

£5.83B

EPS (TTM)

£1.42

P/E Ratio

13.17

Dividend

£0.67

Beta (Volatility)

0.01 (Low)

Dividend

£0.67

Beta (Volatility)

0.01 (Low)

Price

£19.20

Volume

668,353

Open

£19.16

Price

£19.20

Volume

668,353

Open

£19.16

Previous Close

£19.02

Daily Range

£19.08 - £19.26

52-Week Range

£13.15 - £22.82

Estimated Earnings Date

Jul 28, 2026

Dividend

£0.67

Beta (Volatility)

0.01 (Low)

Price

£19.20

Volume

668,353

Open

£19.16

Previous Close

£19.02

Daily Range

£19.08 - £19.26

52-Week Range

£13.15 - £22.82

Estimated Earnings Date

Jul 28, 2026

GSK News

What These Ratios Tell Us About GlaxoSmithKline

Roland HeadJun 25, 2013

Is It Still Safe to Buy GlaxoSmithKline?

Rupert HargreavesJun 24, 2013

The Beginners' Portfolio: What's Been Happening to Vodafone, Tesco, and GlaxoSmithKline?

Alan OscroftJun 21, 2013

3 Things to Loathe About GlaxoSmithKline

G. A. ChesterJun 21, 2013

Why I Think GlaxoSmithKline Is So Much More Than Just an Income Stock

Motley Fool StaffJun 20, 2013

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About GSK

Industry

Pharmaceuticals

Sector

Health Care

Employees

66,841

CEO

Luke Miels, MBA

Website

www.gsk.com

Headquarters

Brentford, TW8 9GS, GB

GSK Financials

Key Financial Metrics (TTM)

Gross Margin

73%

Operating Margin

22%

Net Income Margin

18%

Return on Equity

36%

Return on Capital

18%

Return on Assets

Earnings Yield

7.59%

Dividend Yield

3.52%

Payout Ratio

44.52%

Stock Overview

Market Cap

£76.28B

Shares Outstanding

4.01B

Volume

668.35K

Avg. Volume

8.17M

Financials (TTM)

Gross Profit

£23.70B

Operating Income

£7.17B

EBITDA

£11.88B

Operating Cash Flow

£7.30B

Capital Expenditure

-£1.35B

Free Cash Flow

£5.96B

Cash & ST Invst.

£3.16B

Total Debt

£17.72B

GSK Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

£7.63B

+1.5%

Gross Profit

£5.75B

+2.9%

Gross Margin

75.42%

N/A

Market Cap

£76.28B

N/A

Market Cap/Employee

£1.11M

N/A

Employees

68,629

N/A

Net Income

£1.74B

+7.0%

EBITDA

£2.77B

-10.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

-£15.61B

-448.1%

Accounts Receivable

£7.76B

+9.9%

Inventory

£6.16B

+2.6%

Long Term Debt

£14.01B

N/A

Short Term Debt

£5.04B

N/A

Return on Assets

9.27%

N/A

Return on Invested Capital

18.11%

N/A

Free Cash Flow

£698.00M

+0.1%

Operating Cash Flow

£1.14B

-0.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HLN.LHaleon plc

HLN.LHaleon plc£3.33+1.03%

HIK.LHikma Pharmaceuticals PLC

HIK.LHikma Pharmaceuticals PLC£14.72+0.83%

HCM.LHUTCHMED (China) Limited

HCM.LHUTCHMED (China) Limited£1.63-5.80%

BXP.LBeximco Pharmaceuticals Limited

BXP.LBeximco Pharmaceuticals Limited£0.43+0.00%

BVXP.LBioventix PLC

BVXP.LBioventix PLC£16.58+1.10%

RUA.LRUA Life Sciences plc

RUA.LRUA Life Sciences plc£0.19-3.33%

N4P.LN4 Pharma Plc

N4P.LN4 Pharma Plc£0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

STISolidion Technology

STISolidion Technology$22.71+3.51%

NOKNokia

NOKNokia$16.62-0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$37.76+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.64-0.02%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$36.02-0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$85.22-0.02%

FFord Motor Company

FFord Motor Company$15.36-0.02%

Questions About GSK

What is the current price of GSK?

GSK is trading at £19.20 per share.

What is the 52-week range for GSK?

Over the past 52 weeks, GSK has traded between £13.15 and £22.82.

How much debt does GSK have?

As of the most recent reporting period, GSK reported total debt of £19.06B.

How much cash does GSK have on hand?

GSK reported £3.44B in cash and cash equivalents in its most recent financial results.

What is GSK’s dividend yield?

GSK currently has a dividend yield of 3.52%.

GSK

GSK Financials at a Glance

GSK News

3 Dividend Stocks That Pay You More Than Exxon Does

A Big Pharma Sex Tape Compounds China Woes

Sex, Drugs, and China Woes

What These Ratios Tell Us About GlaxoSmithKline

Is It Still Safe to Buy GlaxoSmithKline?

The Beginners' Portfolio: What's Been Happening to Vodafone, Tesco, and GlaxoSmithKline?

3 Things to Loathe About GlaxoSmithKline

Why I Think GlaxoSmithKline Is So Much More Than Just an Income Stock

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About GSK

GSK Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

GSK Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GSK

What is the current price of GSK?

What is the 52-week range for GSK?

How much debt does GSK have?

How much cash does GSK have on hand?

What is GSK’s dividend yield?

Premium Investing Services